GlaxoSmithKline PLC News Headlines

GSK 
$49.1
*  
0.23
0.47%
Get GSK Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

New Criminal Actions Against Volkswagen, U.S. Meat Supplier
9/1/2014 6:23:00 AM - Seeking Alpha

Is GlaxoSmithKline A Solid Long-Term Investment?
8/29/2014 1:46:00 PM - Seeking Alpha

Testing on Experimental Ebola Vaccine to Begin in U.S.
8/28/2014 12:06:00 PM - Dow Jones Business News

Why GlaxoSmithKline (GSK) Stock Is Gaining Today
8/28/2014 10:32:00 AM - TheStreet

Growth Prospects Remain Strong For Pfizer
8/27/2014 3:44:00 PM - Seeking Alpha

Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade
8/27/2014 3:12:00 PM - Seeking Alpha

Ligand's Partner GSK Gets FDA Approval Of SNDA For Promacta/Revolade
8/27/2014 8:15:00 AM - RTT News

European Stocks Seen Subdued After Rally
8/27/2014 2:04:00 AM - RTT News

GSK: FDA OKs Promacta SNDA In Patients With Aplastic Anaemia
8/26/2014 6:00:00 PM - RTT News

Closing Update: Dow, S&P 500 Finish With New Records, Supported by Cyclical Stocks, Positive Data
8/26/2014 4:08:37 PM - MT Newswires

Sector Update: Health Care Stocks Climbing in Late Trade; Merck Hits 11-Year High After Teaming Up With Pfizer on Cancer Treatment
8/26/2014 3:31:53 PM - MT Newswires

Sector Update: Health Care
8/26/2014 3:26:51 PM - MT Newswires

4 Foreign Blue-Chip Stocks With 4% Dividend Yields to Buy
8/26/2014 1:00:00 PM - TheStreet

Sector Update: Health Care Stocks Rising; Genetic Technologies Rallies After Judge Allows GSK Patent Fight to Proceed
8/26/2014 12:45:43 PM - MT Newswires

Sector Update: Health Care
8/26/2014 12:42:26 PM - MT Newswires

Should Gilead Sciences, inc. Fear This New Competitor Drug?
8/26/2014 11:41:35 AM - Motley Fool

ViiV Healthcare's Single-Pill HIV Drug Triumeq Cleared by FDA - Analyst Blog
8/25/2014 4:30:00 PM - Zacks.com

Big deals push biotech stocks higher
8/25/2014 3:53:00 PM - Market Intelligence Center

Why Jim Cramer Thinks Merck (MRK), Pfizer (PFE), GlaxoSmithKline (GSK) Bids Are Coming After InterMune (ITMN) Deal
8/25/2014 1:24:00 PM - TheStreet

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog
8/21/2014 5:05:00 PM - Zacks.com

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market
8/21/2014 9:32:00 AM - Seeking Alpha

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog
8/20/2014 6:13:00 PM - Zacks.com

Closing Update: Stocks Scratch Out Small Gains After Fed Minutes Point to Eventual Rate Moves
8/20/2014 4:18:06 PM - MT Newswires

GSK Gets FDA Approval For Asthma Drug Arnuity Ellipta
8/20/2014 4:11:00 PM - RTT News

Sector Update: Health Care Stocks Rebound Late; Amicus Therapeutics Gives Up Much of Wednesday Advance
8/20/2014 3:54:05 PM - MT Newswires